The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2017 | Exploring new worlds: the epigenetic contributors to multiple myeloma
Although researchers are aware of the fact that epigenetic factors play a significant role in the development of multiple myeloma (MM), we do not yet understand these factors to the level we do the genomic components of the disease. Speaking from the Myeloma 2017 meeting held in Edinburgh, UK, Felipe Prosper Cardoso, MD, from the University of Navarra, Pamplona, Spain, explains why this is the case, and discusses his talk at the meeting, where he covered a new high-throughput technology, designed to study the changes in chromatin structure between MM and non-MM cells, and our current understanding of the epigenetics of MM.
